IGFL2 and pulmonary fibrosis: Particularly the insulin-like growth factor like family member 2 (IGFL2) was identified as differentially expressed gene in human idiopathic pulmonary fibrosis tissues correlating with lung function [60], and thus might represent a potential therapeutic target.